Literature DB >> 23922180

Pharmaceutical enhancement and medical professionals.

Gavin G Enck1.   

Abstract

Emerging data indicates the prevalence and increased use of pharmaceutical enhancements by young medical professionals. As pharmaceutical enhancements advance and become more readily available, it is imperative to consider their impact on medical professionals. If pharmaceutical enhancements augment a person's neurological capacities to higher functioning levels, and in some situations having higher functioning levels of focus and concentration could improve patient care, then might medical professionals have a responsibility to enhance? In this paper, I suggest medical professionals may have a responsibility to use pharmaceutical enhancements. In some situations, having higher functioning levels of focus and concentration is conducive to providing the best possible care to a patient. In these circumstances medical professionals should use pharmaceutical cognitive enhancements. I conclude by examining the limitations and implications of this responsibility in the practice of medicine and areas for future research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23922180     DOI: 10.1007/s11019-013-9507-z

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  6 in total

1.  The use and misuse of prescription stimulants as "cognitive enhancers" by students at one academic health sciences center.

Authors:  John B Bossaer; Jeffrey A Gray; Stacy E Miller; Gavin Enck; Vamsi C Gaddipati; Robert E Enck
Journal:  Acad Med       Date:  2013-07       Impact factor: 6.893

2.  Cognitive enhancement drug use among future physicians: findings from a multi-institutional census of medical students.

Authors:  Robyn M Emanuel; Sandra L Frellsen; Kathleen J Kashima; Sandra M Sanguino; Frederick S Sierles; Cathy J Lazarus
Journal:  J Gen Intern Med       Date:  2013-08       Impact factor: 5.128

3.  A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor.

Authors:  K Gehring; S Y Patwardhan; R Collins; M D Groves; C J Etzel; C A Meyers; J S Wefel
Journal:  J Neurooncol       Date:  2011-10-02       Impact factor: 4.130

Review 4.  Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals.

Authors:  M Elizabeth Smith; Martha J Farah
Journal:  Psychol Bull       Date:  2011-09       Impact factor: 17.737

5.  Stimulant medication use, misuse, and abuse in an undergraduate and graduate student sample.

Authors:  Barbara Prudhomme White; Kathryn A Becker-Blease; Kathleen Grace-Bishop
Journal:  J Am Coll Health       Date:  2006 Mar-Apr

6.  Modafinil's effects on simulator performance and mood in pilots during 37 h without sleep.

Authors:  John A Caldwell; J Lynn Caldwell; Jennifer K Smith; David L Brown
Journal:  Aviat Space Environ Med       Date:  2004-09
  6 in total
  2 in total

1.  The enhancement debate.

Authors:  Bert Gordijn; Henk ten Have
Journal:  Med Health Care Philos       Date:  2014-02

2.  How cognitive enhancement can change our duties.

Authors:  Filippo Santoni de Sio; Nadira Faulmüller; Nicole A Vincent
Journal:  Front Syst Neurosci       Date:  2014-07-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.